Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
WSC 2022
ECTRIMS 2022
MS at the Limits 2022
EHDN 2022
MDS 2022
EEC 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Uwe Reuter
1:13
Discontinuation and reinitiation of migraine treatment with GCRP mAbs
Uwe Reuter
• 25 Jun 2022
1:18
REGAIN trial of galcanezumab in chronic migraine
Uwe Reuter
• 25 Jun 2022
1:51
Unmet needs in migraine: addressing inter-ictal burden
Uwe Reuter
• 25 Jun 2022
2:09
Challenges in migraine management
Uwe Reuter
• 22 May 2020
3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter
• 22 May 2020
2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter
• 22 May 2020
2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter
• 22 May 2020
2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter
• 22 May 2020
